4LEHRNBECHER T. Hematopoietic growth factors in the prevention of infections complications in children with hematologic-oncologic diseases[J]. Klin Padiatr, 2001, 213(9): 88-102.
5LEX C, KORHOLZ D, KOHLMULLER B, et al. Infectious complications in children with acute lymphoblastic leukemia and T-cell lymphoma-a rationale for tailored supportive care[J]. Support Care Cancer, 2001, 9(7): 514-521.
6CHERIF H, KRONVALL G, BJORKHOLM M, et al. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis [J].Hematol J, 2003, 4(6): 420-426.
7SASADA M. Pathophysiological aspects of neutrophils-dual action of neutrophils[J]. Rinsho Ketsueki, 2003, 44(6): 351-357.
8SUNG L, NATHAN PC, LANGE B, et al. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colonystimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials[J]. J Clin Oncol, 2004, 22(16): 3350-3356.
